Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection

Citation
H. Regele et al., Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection, NEPH DIAL T, 16(10), 2001, pp. 2058-2066
Citations number
20
Categorie Soggetti
Urology & Nephrology
Journal title
NEPHROLOGY DIALYSIS TRANSPLANTATION
ISSN journal
09310509 → ACNP
Volume
16
Issue
10
Year of publication
2001
Pages
2058 - 2066
Database
ISI
SICI code
0931-0509(200110)16:10<2058:ECDIAW>2.0.ZU;2-7
Abstract
Background. Capillary deposition of complement split product C4d has been s uggested to be a valuable marker for humoral rejection. In this retrospecti ve study we evaluated the clinical impact of C4d deposition in renal allogr afts with special emphasis on associations between C4d staining patterns an d histological features of acute rejection. Methods. One hundred and two allograft biopsies obtained from 61 kidney tra nsplants (1-532 days after transplantation, median 14 days) were examined b y immunohistochemistry on routine paraffin sections using a novel anti-C4d polyclonal antibody (C4dpAb). Results. Fourty-two of 102 biopsies showed endothelial C4d deposits in peri tubular capillaries (PTC). Histopathological analysis revealed a significan tly lower frequency of positive C4d staining in biopsies with rather than i n those without acute cellular rejection defined by the Banff grading schem a (P <0.01). For clinical evaluation, patients were classified according to C4d staining in allografts C4d(PTC) positive in at least one biopsy, n=31 vs C4d(PTC)( negative in all biopsies, n = 30). C4d(PTC) positive patients had significantly higher serum creatinine levels than C4d negative patients . Even in the absence of morphological evidence for rejection, differences in serum creatinine levels between C4dPTC positive and negative recipients were significant (6 months: 2.01 +/- 0.75 rs 1.41 +/- 0.27 mg/dl; 12 months : 1.95 +/- 0.60 vs 1.36 +/- 0.34 me dl, 18 months: 1.98 +/- 0.50 vs 1.47 +/ - 0.31 mg, dl. P <0.05). All patients with rejection resistant to conventio nal therapy (n=4) were in the C4d(PTC) positive subgroup. All recipients wi th panel reactive antibodies (PRA) > 50% (n = 8) were C4dPTC positive. Conclusions. Our data indicate that endothelial C4d deposition is associate d with inferior graft outcome. We provide evidence that this immunohistoche mical finding and its clinical impact are not associated with morphological signs of cellular rejection.